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Bombax buonopozense is used in ethnomedical practice for the treatment of fever. The methanol leaf 
extract of this plant was evaluated for in vivo antiplasmodial activity against chloroquine sensitive plasmodium 
berghei in mice. The antiplasmodial effect during early and established infections was investigated. The extract 
(200-600 mg/kg, p.o) exhibited significant (P<0.05) antimalarial activity both in four-day early and in an 
established infection tests. The LD50 of the extract was established to be greater than 5000 mg/kg, p.o in mice. 
The result suggests that B. buonopozense l af extract possesses significant (P< 0.05) antiplasmodial activity 
thus confirming its traditional use in malarial therapy. 
© 2011 International Formulae Group. All rights reserved. 
 




Malaria is one of the most important 
parasitic diseases in the world. It remains a 
major public health problem in Africa 
responsible for annual death of over one 
million people (David et al., 2004; Martin et 
al., 2004). Plasmodium falciperum, the most 
important human parasitic infection 
(Greenwood et al., 2005), is becoming 
increasingly resistant to standard antimalaria 
drugs which necessitate a continuous effort to 
search for new drugs, particularly with novel 
modes of action (Muregi et al., 2003). One of 
the areas for the search of new antimalarial 
agent is the traditionally claimed antimalarial 
plant from the African flora (Whitefield, 
1995). For a long period of time medicinal 
plants have been the focus of many anti-
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infective drugs and alternative sources of 
antimalarial agents in different parts of the 
world. Studies have been conducted on the in 
vivo antimalarial properties of several plant 
extracts in mice (Agbaje and Onabanjo, 1991; 
Perez et al., 1994; Andre-Neto et al., 2003). 
Interestingly, some of the plants used have 
shown real antiparasitic activity (Hilou et al., 
2006) and most of them are relatively safe 
(Ajaiyeoba et al., 2006; Kaou et al., 2008). 
Bombax buonopozense P.beauv. 
(Bombacaceae) is a large tropical tree that 
grows to 40 metres in height with large 
buttress roots that can spread 6 metres. The 
bark is covered in large conical spines, 
especially when young but shedding them 
with age to some degree. The branches are 
arranged in whorls; the leaves are compound 
and have 5-9 leaflets and 5-25 secondary 
veins. The individual leaflets have entire 
margins and are also large. The undersides of 
the leaflets may be glabrous or puberclous 
(Beentje and Sara, 2001). It is widely 
distributed in Africa from Ghana to Sierra 
Leone, Uganda and Gabon. Many parts of the 
plant are used for medicinal purposes, as food, 
as a source of clothing fibre, as a building 
material, as cotton wool and as dye. The fruits 
are eaten by animals such as water chevrotain 
(Dubost, 1984). A decoction of the leaf is 
used for feverish conditions, diarrhoeal and 
pains. Root decoction is also used for 
antimicrobial and stomach aches. Therefore, 
this study aims at investigating the in vivo 
antiplasmodial activity of the leaf extract of B.
buonopozense against P. berghei infection in 
mice. 
 
MATERIALS AND METHODS 
Plant material 
The leaves of B. buonopozense were 
collected at Chaza Village, Suleja, Niger 
State, Nigeria in April 2009. The plant was 
identified and authenticated by Mrs Grace 
Ugbabe, a taxonomist in the Department of 
Medicinal Plant Research and Traditional 
Medicine, National Institute for 
Pharmaceutical Research and Development 
(NIPRD), Abuja, Nigeria. A voucher 
specimen (No.6402) was deposited at the 
herbarium of the Institute. 
 
Preparation of plant extract 
The plant material was air-dried at 
room temperature and pulverized into a dry 
powder, and macerated with 70% methanol in 
water for 72h with constant shaking. The 
resultant mixture was filtered using whatman 
(No. 1) filter paper and the filtrate 
concentrated using rotary evaporator and dried 
on a water bath to give a yield of 7.7% (w/w). 
The extract was reconstituted in normal saline 




Adult male and female Swiss albino 
mice (18-25 kg) maintained at the Animal 
facility Centre of NIPRD was used. The 
animals were maintained with standard diet 
and had water ad libitum. The studies were 
carried out following the ethical norms of 
‘NIH Guide for the Care and Use of 
Laboratory Animals; NIH publication (No 83-
23), The National Academic Press, 
Washington, DC (1985). 
 
Acute toxicity study 
The median lethal dose (LD50) of the 
extract was estimated p.o. following Lorke’s 
(1983) method. Dose levels used ranged from 
10-5000mg/kg. The acute toxicity LD50 was 
calculated as geometric mean of the dose that 
resulted in 100% lethality and that which 
caused no lethality at all. 
 
Phytochemical analysis  
Phytochemical screenings were 
performed using standard procedures (Trease 
and Evans, 1989; Sofowora, 1993). 
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Test for tannins 
About 0.5 g of the extract was boiled in 
10 ml of water in a test tube and then filtered. 
A few drops of 0.1% ferric chloride was 
added and observed for brownish green or a 
blue-black colouration. 
 
Test for saponins 
To 0.5 g of the extract was added 5 ml 
of distilled water in a test tube. The solution 
was shaken vigorously and observed for a 
stable persistent froth. The frothing was mixed 
with 3 drops of olive oil and shaken 
vigorously after which it was observed for the 
formation of an emulsion. 
 
Test for terpenoids 
To 0.5 g each of the extract was added 
2 ml of chloroform. Concentrated H2S04 (3 
ml) was carefully added to form a lower layer. 
The formation of a reddish-violet colour in the 
chloroform layer indicates the presence of 
terpenoids. 
 
Test for flavonoids 
Three methods were used to test for 
flavonoids. Firstly, dilute ammonia (5 ml) was 
added to a portion of an aqueous filtrate of the 
extract. Concentrated H2S04 (1 ml) was added. 
A yellow colouration that disappears on 
standing indicates the presence of flavonoids. 
Secondly, a few drops of 1% aluminium 
solution were added to a portion of the filtrate. 
A yellow colouration indicates the presence of 
flavonoids. Thirdly, a portion of the extract 
was heated with 10 ml of ethyl acetate over a 
steam bath for 3 min. The mixture was filtered 
and 4 ml of the filtrate was shaken with 1 ml 
of dilute ammonia solution. A yellow 
colouration indicates the presence of 
flavonoids. 
 
Test for alkaloids 
0.5 g of the extract was diluted to 10 ml 
with acid alcohol, boiled and filtered. To 5 ml 
of the filtrate was added 2 ml of dilute 
ammonia. 5 ml of chloroform was added and 
shaken gently to extract alkaloidal base. The 
chloroform layer was extracted with 10 ml of 
acetic acid. This was divided into two 
portions. Mayer’s reagent was added to one 
portion and Draggendorff’s reagent to the 
other. The formation of a cream (with 
Mayer’s reagent) or reddish brown precipitate 
(with Draggendorff’s reagent) was regarded as 
positive for the presence of alkaloids. 
 
Test for steroids  
To 0.5 g each of the extract was added 
2 ml of chloroform. Concentrated H2S04 (3 
ml) was carefully added to forma layer. A 
reddish brown colour at the interface indicates 
the presence of steroidal ring. 
 
Test for carbohydrates 
About 0.5 g of the extract was boiled in 
10 ml of water in a test tube and then filtered. 
A few drops of concentrated sulphuric acid 
was added and allowed to form a lower layer. 
A purple ring at the interface of the liquids 
indicates the presence of carbohydrates. 
 
Parasite inoculation 
The chloroquine- sensitive Plasmodium 
berghei berghei (NK65 Strain) was sourced 
from National Institute for Medical Research 
(NIMR), Lagos, Nigeria and maintained in 
NIPRD by continuous reinfestation (i.p.) 
(Calvalho et al., 1991) every 4 days.  Blood 
was collected from a donor infected mouse 
through cardiac puncture and diluted with 
normal saline. The mice received 0.2 ml of 
diluted inoculums i.p. consisting of 107 
parasitized red blood cells. 
 
Evaluation of Schizonticidal activity on 
early infection 
Tests were performed in a 4 day 
suppressive standard test using the methods of 
Peters et al. (1993) and David et al. (2004) 
with slight modifications. Thirty Swiss albino 
mice of both sexes weighing (18-25 g) were 
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inoculated intrapertoneally with infected red 
blood cells (0.2 ml) containing 1x107 P. 
berghei. The animals were divided into five 
groups (n=6). Group 1 which served as 
negative control received normal saline (10 
ml/kg) p.o. Group 2- 4 received (200, 400 and 
600 mg/kg) of B. buonopozense xtract orally, 
while group 5 received 10 ml/kg of 
chloroquine as the positive control i.p., all on 
the first day (Do). Treatment continued daily 
for four days (D1-D4). On the fifth day, blood 
was collected from the tail of each mouse and 
thick films made. The films were fixed with 
methanol, stained with Giemsa for 30 min and 
parasitaemia examined microscopically for 
blood parasite suppression.  
 
Curative test  
Evaluation of curative potential of B. 
buonopozense leaf extract was done using a 
method described by (Ryley and peters, 1970) 
with slight modifications. Thirty mice were 
selected and intraperitoneally injected with 
standard inoculums of 1x107 Plasmodium 
berghei infected red cells on the first day. 
Seventy two hours after (D4), the animals 
were divided into five groups (n=6). Group 1 
received normal saline 10 ml/kg as the 
negative control. Groups 2-4 received (200, 
400 and 600 mg/kg) of the extract, all 
administered orally. Group 5 received 10 
mg/kg chloroquine as the positive control i.p.  
Treatment continued daily until the seventh 
day (D4-D7) when blood was collected from 
the tail of each mouse and thick films made. 
The films were fixed with methanol, stained 
with Giemsa for 30 min and parasitaemia 
density determined (Akuodor et al., 2010b). 
The survival time of the mice in each group 
over 30 days was noted (Saidu et al., 2000).  
 
Statistical analysis 
Results obtained were expressed as 
mean + Standard Error of Mean (S.E.M). The 
data was analyzed using student’s t-test. 
P<0.05 was considered significant. 
RESULTS 
Phytochemical screening 
A phytochemical analysis of the crude 
extract gave positive reaction for each of the 
following secondary metabolites; Tannins, 
saponins, terpenes, steroids, flavonoids, 
alkaloids and carbohydrates. 
 
Acute toxicity tests 
There was no lethality observed in mice 
upon oral administration, even at dose as high 
as 5000 mg/kg signifying that the LD50 was 
greater than 5000 mg/kg. Apart from sedation 
and weakness, B. buonopozense did produce 
any sign of toxicity in mice during 72 h 
observation period. This indicates that the 
experimental doses used are relatively safe. 
 
4-days test 
The methanol extract of B. 
buonopozense produced a dose-dependent 
chemosuppressive activity at doses employed, 
(200, 400 and 600 mg/kg/day) with 
chemosuppression of 65%, 78% and 86% 
respectively. However, the standard drug 
chloroquine 10mg/kg/day caused 90% 
suppression which was significantly (P<0.05) 




On established infection, the extract 
caused a significant (P< 0.05) and dose-
dependent reduction in the mean parasitemia 
in mice, similar to chloroquine 10 mg/kg. In 
the extract groups that received 400 and 600 
mg/kg orally, only three deaths each were 
recorded and none in chloroquine group 
throughout the 30 days observation period of 
the study while the remaining mice recovered 
fully. However, all the mice in the saline 
group were lost within 10 days of the 
experiment (Table 2). 
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Table 1: Suppressive effect of B. buonopozense against P. berghei in mice. 
 
Treatment                     Dose           Mean parasitaemia density          % inhibition 
                                      (mg/kg)                         D5 
Control                           10 ml/kg         38.23 + 1.87                                __ 
Extract                            200                      13.3 + 0.33                                 65* 
                                       400                       8.43+ o.52                                  78* 
                                       600                       5.72 + 0.55                                 86* 
CQ                                  10                         3.78 + 1.07                                90* 
D5=Day five , CQ= chloroquine. *significantly differ nt from control at P<0.05 
 
 
Table 2: Curative effect of B. buonopozense against P. berghei in mice 
 
Treatment               Dose               Mean parasitemia density                    Survival time  
                                 (mg/kg)          Pre- (D3)          Post-(D7)-treatment        (Days)   
   Control                    10 ml/kg      34.26+ 3.11           40.32+1.21                   10.0+2.0 
   Extract                     200               27.53+ 2.30           12.63+0.47*                25.4+1.0 
                                    400              30.43+ 3.15             8.4+0.29*                   28.0+0.8 
                                    600              32.46+ 4.13             4.67+0.59 *                29.2+0.5 
    CQ                           10                29.30+ 1.21             2.9+0.61*                   30.0+0.0 




In this study, phytochemical screening 
and evaluation of antiplasmodial activity of 
the leaf extract of B. buonopozense were 
carried out. Alkaloids, flavonoids and terpenes 
which have been implicated in antiplasmodial 
activities of plant substances (Phillipson and 
Wright, 1990; Christensen and Kharazmi, 
2001) are found in the extract studied. 
The results of this study suggest that B. 
buonopozense contains active substances with 
potential values in the treatment of malaria as 
shown from chemosupression obtained during 
the 4-day early infection test. However, on 
established infection, the extract exerted a 
significant (P<0.05) curative activity. Agents 
with suppressive activity against P. berghei 
were known for antimalarial activity 
(Calvalho et al., 1991). The antiplasmodial 
activity of the extract at all doses during early 
and established infections was not comparable 
to chloroquine, the referenced drug. There 
was a dose-dependent chemosuppression of 
parasitemia observed with the extract. The 
fact that some of the mice in the group 
administered 400 and 600 mg/kg of the plant 
extract survived throughout the 30 days 
observation period similar to the chloroquine-
treated group shows a high level of efficacy, 
indicative of its potential as a 
chemotherapeutic antimalarial agent. 
Although the mechanism of action of this 
extract has not been elucidated, some plants 
are known to exert antiplasmodial activity 
either by causing red blood cell oxidation 
(Etkin, 1997) or by inhibiting protein 
synthesis (Kirby et al., 1989) depending on 
their phytochemical constituent. B. 
buonopozense could have exerted its action 
through either of the two mechanisms 
mentioned or by other unknown mechanism. 
In addition, our earlier studies have shown 
that methanolic leaf extract of B. 
buonopozense has analgesic effect (Akuodor 
et al., 2011). Agents with such activity were 
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reported to provide relief to malaria patients 
(Addae-Kyereme et al., 2001). 
The results of the present study have 
shown that the methanolic extract of B. 
buonopozense possesses antiplasmodial 
activity as seen in its ability to suppress 
Plasmodium berghei infection in the two 
evaluated animal models. The study strongly 




The authors are grateful to Ngozi 
Anyalewechi A. for her secretarial assistance.  
 
REFERENCES 
Addae- Kyereme J, Croft S, Kendrick H, 
Wright CW. 2001. Antiplasmodial 
activities of some Ghanaian plants 
traditionally used for fever/ malaria 
treatment and of some alkaloids isolated 
from Pleiocarpa mutica in vivo 
antimalarial activity of Pleiocarpine. J. 
Ethnopharmacol., 76: 99-103. 
Ajaiyeoba EO, Abiodun OO, Falade MO, 
Ogbole NO, Ashidi JS, Happi CT, 
Akinboye DO. 2006. In vitro cytotoxicity 
studies of 20 plants used in Nigerian 
antmalaria ethnomedicine. Phytomedi-
cine, 13: 295-298. 
Akuodor GC, Idris-Usman Maryam, Ugwu 
Theresa C, Akpan JL, Ghasi SI, Osunkwo 
UA. 2010b. In vivo schizonticidal activity 
of ethanolic leaf extract of Gongronema 
latifolium on Plasmdium berghei berghei 
in mice. Ibnosina J. Med. Biomed. Sci., 
2(3): 118-124. 
Akuodor GC, Idris- Usman M, Ibrahim JA, 
Chilaka KC, Akpan JL, Dzarma S, 
Muazzam I andOsunkwo UA. 2011c. 
Anti-nociceptive anti-inflammatory and 
antipyretic effects of the methanolic 
extract of Bombax buonopozense l aves 
in rats and mice. Afri. J. Biotechnol., 
10(16): 3191-3196. 
Andre-Neto VF, Brandao MGL, Stehmann 
JR, Oliveira LA, Krettli AU. 2003. 
Antimalarial activity of Cinchona like 
plants used to treat fever and malaria in 
Brazil. J.  Ethnopharmacol., 87: 253-256. 
Agbeje EO, Onabanjo AO. 1991. The effects 
of extracts of Enantia chlorantha in 
malaria. Ann. Trop. Med. Parasitol., 85: 
588-590. 
Beentje H, Sara S. 2001. Plant systematic and 
Phytogeography for the understanding of 
African Biodiversity. Systematic and 
Geography of Plants, 71(2): 284-286.       
Calvaho LH, Brandao MGL, Santos-Filho D, 
Lopes JLC, Krettli UA. 1991. 
Antimalaria activity crude extract from 
Brazilian plants studied in vivo in 
Plasmodial berghei-infected mice and in 
vitro against Plasmodium falciparium  in 
culture. Braz. J. Med. Biol. Res., 24: 
1113-1123. 
Christensen SB, Kharazmi A. 2001. 
Antimalaria natural product isolation, 
characterization and biological properties. 
In Bioactive Compound from Natural 
Sources: Isolation, Characterization and 
Biological Properties, Tringali C (ed). 
Taylor and Francis; 379-432. 
David F, Philip JR, Simon IC, Reto B, 
Solomon N. 2004. Antimalaria drug 
discovery: Efficacy model for compound 
screening. Nature Reviews, 3: 509-520. 
Dubost G. 1984. Comparison 0f the diets of 
frugivorous forest mammals of Gabon. 
Journal of Mammalogy, 65(2): 298-316. 
Etkin NL. 1997. Antimalarial plants used by 
Hausa in northern Nigeria. Tropical 
Docto., 27: 12-16. 
Greenwood BM, Bojang K, Wihitty CJM, 
Targett GAT. 2005. Malaria. The Lancet, 
365: 1487-1898.  
Hilou A, Nacoulma OG, Guiguemde TR. 
2006. In vivo antimalaria activities of 
extracts from      Amaranthus spinosus L 
and Boerhaavia erecta L. in mice. J. 
Ethnopharmacol., 103: 236-240. 
Kaou Am, Mahiou-Leddet V, Hutter S, 
Ainouddine S, Hassani S, Yahaya I, Azas 
N, Ollivier E.     2008. Antimalarial 
activity of crude extracts from nine 
G. C. AKUODOR et al. / Int. J. Biol. Chem. Sci. 5(5): 1790-1796, 2011 
 
 1796
African medicinal plants. J.       
Ethnopharmacol., 116: 74-83.  
Kirby JC, O’Neil NJ, Philipson JD, Warhust 
DC. 1989. In vitro studies on the mode of 
action quassionoids with activity against 
chloroquine-resistant Plasmodium 
falciparum. Biochem. Pharmacol., 38: 
4367-4374. 
 Lorke D. 1983. A new approach to acute 
toxicity testing. Archives of Toxicology, 
54: 275-287. 
Martin SA, Bygbjerg IC, Joil GB. 2004. Are 
multilateral malaria researches and 
control  programs the most successful ? 
Lessons from the past 100 years in 
Africa. Am. J. Trop Med Hyg., 2: 268-
278.    
Muregi FW, Chhabra SC, Njagi, ENM, 
Lang’at-Thoruwa CC, Njue WM, Orago 
ASS, Omar SA, Ndiege IO. 2003. In vitro 
antiplasmodial activity of some plants 
used in Kisii, Kenya against malaria and 
their chloroquine potentiation effects. J
Ethnopharmacol., 84: 235-239. 
NIH. 1985. Guide for the Care and Use of 
Laboratory Animals. NIH publication no. 
85-23. The National Academic Press: 
Washington, DC.    
Philips JD, Wright, CW. 1990. Antiprotozoal 
compounds from plants sources. Planta 
Medica., 57: 553-559. 
Perez HA, Dela Rosa M, Apitz R. 1994. In 
vivo activity of ajoene against rodent 
malaria. Antimicrob.  Agents Chemother., 
38: 337-339. 
 Peters W, Robinson BL, Tovey G, Rossier 
JC, Jefford CW. 1993. The chemotherapy 
of rodent malaria. 1. The activities of 
some synthetic 1,2,4-trioxanes against 
chloroquine-sensitive and chloroquine 
resistant parasites. Part 3. Observations 
on ‘Fenozan-50 F’ a di-flurated 3, 3’- 
spirocyclopentane 1,2,4-trioxane. Annals 
Trop. Med. Parasitol., 87: 111-123. 
 Ryley JF, Peters W. 1970. The antimalarial 
activity of some quinoline esters. Annals 
Trop. Parasitol., 64: 209-222. 
Saidu  K,  Onah  J,  Orisadipe  A, Olusola  A, 
Wambebe  C, Gamaniel  K.  2000. 
Antiplasmodial, analgesic and anti-
inflammatory activities of the aqueous 
extract of the stem bark of Erythrina 
senegalensis. J. Ethnopharmacol., 71: 
275-280. 
Sofowora A. 1993. Medicinal Plants and 
Traditional Medicine in Africa. Spectrum 
Books: Ibadan; 150. 
Trease GE, Evans WC. 1989. Textbook of 
Pharmacognosy (13th edn). Bailliere 
Tindall: London; 176-180. 
Whifield PJ. 1995. Plant allelochemicals and 
the control of parasites. Bull. Scand. Soc. 
Parasitol., 5: 5-18. 
 
